Leader S, Kohlhase K (2003) Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 143(5 Suppl):S127–S132. https://doi.org/10.1067/s0022-3476(03)00510-9

Article  PubMed  Google Scholar 

Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I et al (2018) Respiratory syncytial virus seasonality: a global overview. J Infect Dis 217(9):1356–1364. https://doi.org/10.1093/infdis/jiy056

Shi T, McAllister DA, O’Brien KL et al (2017) Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet 390(10098):946–958. https://doi.org/10.1016/S0140-6736(17)30938-8

Article  PubMed  PubMed Central  Google Scholar 

Shi T, Denouel A, Tietjen AK et al (2020) Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis. J Infect Dis 222(Supplement_7):S577-S583. https://doi.org/10.1093/infdis/jiz059

Simoes EA (2003) Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 143(5 Suppl):S118–S126. https://doi.org/10.1067/s0022-3476(03)00511-0

Article  PubMed  Google Scholar 

Figueras-Aloy J, Carbonell-Estrany X, Quero J, Group IS (2004) Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33–35 weeks in Spain. Pediatr Infect Dis J 23(9):815–820. https://doi.org/10.1097/01.inf.0000136869.21397.6b

Article  Google Scholar 

Borchers AT, Chang C, Gershwin ME, Gershwin LJ (2013) Respiratory syncytial virus–a comprehensive review. Clin Rev Allergy Immunol 45(3):331–379. https://doi.org/10.1007/s12016-013-8368-9

CAS  Article  PubMed  PubMed Central  Google Scholar 

The IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102(3 Pt 1):531–7

Resch B (2017) Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection. Hum Vaccin Immunother 13(9):2138–2149. https://doi.org/10.1080/21645515.2017.1337614

Wegzyn C, Toh LK, Notario G et al (2014) Safety and effectiveness of palivizumab in children at high risk of serious disease due to respiratory syncytial virus infection: a systematic review. Infect Dis Ther 3(2):133–158. https://doi.org/10.1007/s40121-014-0046-6

Article  PubMed  PubMed Central  Google Scholar 

Mazur NI, Higgins D, Nunes MC et al (2018) The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect Dis 18(10):e295-e311. https://doi.org/10.1016/S1473-3099(18)30292-5

August A, Glenn GM, Kpamegan E et al (2017) A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age. Vaccine 35(30):3749–3759. https://doi.org/10.1016/j.vaccine.2017.05.045

CAS  Article  PubMed  Google Scholar 

Muňoz FM, Swamy GK, Hickman SP et al (2019) Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants. J Infect Dis 220(11):1802–1815. https://doi.org/10.1093/infdis/jiz390

CAS  Article  PubMed  Google Scholar 

Abu-Raya B, Maertens K (2021) Protection of the newborn through vaccination in pregnancy. Neoreviews 22(1):e25-e39. https://doi.org/10.1542/neo.22-1-e25

Esposito S, Pietro GD (2016) Respiratory syncytial virus vaccines: an update on those in the immediate pipeline. Future Microbiol 10(11):1479–1490. https://doi.org/10.2217/fmb-2016-0106

CAS  Article  Google Scholar 

Gerretsen HE, Sande CJ (2017) Development of respiratory syncytial virus (RSV) vaccines for infants. J Infect 74 Suppl 1:S143-S146. https://doi.org/10.1016/S0163-4453(17)30205-0

Madhi SA, Polack FP, Piedra PA et al (2020) Respiratory syncytial virus vaccination during pregnancy and effects in infants. N Engl J Med 383(5):426–439. https://doi.org/10.1056/NEJMoa1908380

Chu HY, Steinhoff MC, Magaret A et al (2014) Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh. J Infect Dis 210(10):1582–1589. https://doi.org/10.1093/infdis/jiu316

CAS  Article  PubMed  PubMed Central  Google Scholar 

Buchwald AG, Graham BS, Traore A et al (2020) RSV neutralizing antibodies at birth predict protection from RSV illness in infants in the first three months of life. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa648

Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL (1981) Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 98(5):708–715. https://doi.org/10.1016/s0022-3476(81)80829-3

CAS  Article  PubMed  Google Scholar 

Chu HY, Tielsch J, Katz J et al (2017) Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal. J Clin Virol 10(95):90–95. https://doi.org/10.1016/j.jcv.2017.08.017

CAS  Article  Google Scholar 

Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD (1991) Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 133(11):1135–1151. https://doi.org/10.1093/oxfordjournals.aje.a115826

CAS  Article  PubMed  Google Scholar 

Hacimustafaoglu M, Celebi S, Aynaci E et al (2004) The progression of maternal RSV antibodies in the offspring. Arch Dis Child 89(1):52–53. https://doi.org/10.1136/adc.2002.017780

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lamprecht CL, Krause HE, Mufson MA (1976) Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis 134(3):211–217. https://doi.org/10.1093/infdis/134.3.211

CAS  Article  PubMed  Google Scholar 

Piedra PA, Jewell AM, Cron SG, Atmar RL, Glezen WP (2003) Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine 21(24):3479–3482. https://doi.org/10.1016/s0264-410x(03)00355-4

Article  PubMed  Google Scholar 

Ogilvie MM, Vathenen AS, Radford M, Codd J, Key S (1981) Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol 7(4):263–271. https://doi.org/10.1002/jmv.1890070403

CAS  Article  PubMed  Google Scholar 

Stensballe LG, Ravn H, Kristensen K et al (2009) Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol 123(2):398–403. https://doi.org/10.1016/j.jaci.2008.10.043

Article  PubMed  Google Scholar 

Eick A, Karron R, Shaw J et al (2008) The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease. Pediatr Infect Dis J 27(3):207–212. https://doi.org/10.1097/INF.0b013e31815ac585

Article  PubMed  Google Scholar 

Nyiro JU, Sande CJ, Mutunga M et al (2016) Absence of association between cord specific antibody levels and severe respiratory syncytial virus (RSV) disease in early infants: a case control study from Coastal Kenya. PLoS ONE 11(11):e0166706. https://doi.org/10.1371/journal.pone.0166706

CAS  Article  PubMed  PubMed Central  Google Scholar 

Bulkow LR, Singleton RJ, Karron RA, Harrison LH, Group ARS (2002) Risk factors for severe respiratory syncytial virus infection among Alaska native children. Pediatrics 109(2):210–216. https://doi.org/10.1542/peds.109.2.210

Article  Google Scholar 

Centers for Diseases Control and Prevention. Respiratory syncytial virus infection. https://www.cdc.gov/rsv/clinical/index.html. Accessed 08 June 2022 

Stensballe LG, Ravn H, Kristensen K, Meakins T, Aaby P, Simoes EA (2009) Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J Pediatr 154(2):296–298. https://doi.org/10.1016/j.jpeds.2008.07.053

Article  PubMed  Google Scholar 

Raghunandan R, Higgins D, Hosken N (2021) RSV neutralization assays - use in immune response assessment. Vaccine 39(33):4591–4597. https://doi.org/10.1016/j.vaccine.2021.06.016

McDonald JU, Rigsby P, Dougall T, Engelhardt OG, Participants S (2018) Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study. Vaccine 36(50):7641–7649. https://doi.org/10.1016/j.vaccine.2018.10.087

McDonald JU, Rigsby P, Atkinson E, Engelhardt OG, Participants S (2020) Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study. Vaccine 38(4):800–807. https://doi.org/10.1016/j.vaccine.2019.10.095

Jennewein MF, Goldfarb I, Dolatshahi S et al (2019) Fc glycan-mediated regulation of placental antibody transfer. Cell 178(1):202–215.e14. https://doi.org/10.1016/j.cell.2019.05.044

Gupta N, LeGoff J, Chamat S et al (2013) Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity. PLoS ONE 8(7):e69390. https://doi.org/10.1371/journal.pone.0069390

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cortjens B, Yasuda E, Yu X et al (2017) Broadly reactive anti-respiratory syncytial virus G antibodies from exposed individuals effectively inhibit infection of primary airway epithelial cells. J Virol 91(10). https://doi.org/10.1128/JVI.02357-16

Arnold R, Werner F, Humbert B, Werchau H, König W (1994) Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes. Immunology 82(2):184–191

CAS  PubMed  PubMed Central  Google Scholar 

van Erp EA, Luytjes W, Ferwerda G, van Kasteren PB (2019) Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease. Front Immunol 10:548. https://doi.org/10.3389/fimmu.2019.00548

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kaul TN, Welliver RC, Ogra PL (1982) Appearance of complement components and immunoglobulins on nasopharyngeal epithelial cells following naturally acquired infection with respiratory syncytial virus. J Med Virol 9(2):149–158. https://doi.org/10.1002/jmv.1890090210

CAS  Article  PubMed  PubMed Central  Google Scholar 

Corbeil S, Seguin C, Trudel M (1996) Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2. Vaccine 14(6):521–525. https://doi.org/10.1016/0264-410x(95)00222-m

CAS  Article  PubMed  PubMed Central  Google Scholar 

Polack FP, Teng MN, Collins PL et al (2002) A role for immune complexes in enhanced respiratory syncytial virus disease. J Exp Med 196(6):859–865. https://doi.org/10.1084/jem.20020781

CAS  Article  PubMed  PubMed Central  Google Scholar 

Murphy BR, Alling DW, Snyder MH et al (1986) Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol 24(5):894–898. https://doi.org/10.1128/jcm.24.5.894-898.1986

CAS  Article  PubMed  PubMed Central  Google Scholar